Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 24.40
-0.10 (-0.41%)
Jul 30, 2026, 9:56 AM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 5.08 billion as of July 29, 2026. Its market cap has decreased by -35.40% in one year.
Market Cap
5.08B
Enterprise Value
6.04B
Revenue
815.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.40
ChartMarket Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 5.08B, an increase of 769.23%. That is a compound annual growth rate of 12.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 5.08B | -22.46% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.06B |
| Sinphar Pharmaceutical | 6.42B |
| Savior Lifetec | 5.87B |
| TaiGen Biopharmaceuticals Holdings | 5.77B |
| TWi Biotechnology | 5.48B |
| Steminent Biotherapeutics | 5.18B |
| AnnJi Pharmaceutical | 5.14B |
| UnicoCell Biomed | 4.86B |